SABS SAB Biotherapeutics, Inc. - Common Stock
$3.85
Price · Aug 19, 2026
52W Range
$2–$5
61% of range
Analyst Rating
BUY
17 analysts
Price Target
$12
+202% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
SABS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.85
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$2 – $5
SABS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
SABS
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
SABS
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
SABS
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
SABS
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
SABS
Peer Median
SABS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
17 analysts
- Strong Buy 7 41.2%
- Buy 9 52.9%
- Hold 1 5.9%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
11 analysts · 2026-08-15
Median
$12.00
← Below all targets
$3.85
Low
$6.00
High
$16.00
Median target
$12.00
+211.7%
Mean target
$11.64
+202.2%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.05%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.28 | $-0.30 | 0.02% |
| March 31, 2026 | $-0.35 | $-0.23 | -0.12% |
| Dec. 31, 2025 | $-0.35 | $-0.20 | -0.15% |
| Sept. 30, 2025 | $-0.15 | $-0.52 | 0.37% |
| June 30, 2025 | $-1.09 | $-0.81 | -0.28% |
| March 31, 2025 | $-0.56 | $-1.05 | 0.49% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SABS | — | — | — | — | — | — |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | — |
| DMAC | $428M | — | — | — | -78.7% | — |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | — |
| ZNTL | $93M | -0.7 | — | — | -49.5% | — |
| TLSI | — | — | — | — | — | — |
| IMRX | — | -5.2 | — | — | -45.3% | — |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | — |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | — |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 91 filers · $250.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 35 (-6 vs prior Q) | 20 (+15 vs prior Q) | 21 (+2 vs prior Q) | 19 (+12 vs prior Q) | -2.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Caligan Partners LP | $31,072,107 | 7,967,207 | 12.41% | Shares |
| Vivo Capital, LLC | $28,469,645 | 7,299,909 | 11.37% | Shares |
| PERCEPTIVE ADVISORS LLC | $25,847,254 | 6,627,501 | 10.32% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $24,981,657 | 6,405,553 | 9.98% | Shares |
| RA CAPITAL MANAGEMENT, L.P. | $17,165,850 | 4,401,500 | 6.86% | Shares |
| Balyasny Asset Management L.P. | $14,665,712 | 3,760,439 | 5.86% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $11,594,423 | 2,972,929 | 4.63% | Shares |
| Commodore Capital LP | $11,193,000 | 2,870,000 | 4.47% | Shares |
| MILLENNIUM MANAGEMENT LLC | $10,721,439 | 2,749,087 | 4.28% | Shares |
| Spruce Street Capital LP | $8,574,158 | 2,198,502 | 3.42% | Shares |
| Sessa Capital IM, L.P. | $8,573,982 | 2,198,457 | 3.42% | Shares |
| Affinity Asset Advisors, LLC | $5,947,500 | 1,525,000 | 2.38% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $5,778,474 | 1,481,660 | 2.31% | Shares |
| Woodline Partners LP | $4,603,385 | 1,180,355 | 1.84% | Shares |
| Ensign Peak Advisors, Inc | $4,573,300 | 1,172,641 | 1.83% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $4,208,065 | 1,078,816 | 1.68% | Shares |
| Propel Bio Management, LLC | $4,198,654 | 1,076,578 | 1.68% | Shares |
| Soleus Capital Management, L.P. | $3,510,000 | 900,000 | 1.40% | Shares |
| AMERIPRISE FINANCIAL INC | $2,382,975 | 611,019 | 0.95% | Shares |
| STATE STREET CORP | $2,070,241 | 530,831 | 0.83% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,710,209 | 438,515 | 0.68% | Shares |
| DV EQUITIES, LLC | $1,560,000 | 400,000 | 0.62% | Shares |
| AWM Investment Company, Inc. | $1,462,500 | 375,000 | 0.58% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,458,522 | 373,980 | 0.58% | Shares |
| STEMPOINT CAPITAL LP | $1,336,261 | 342,631 | 0.53% | Shares |
| Seven Fleet Capital Management LP | $1,310,700 | 336,077 | 0.52% | Shares |
| HB Wealth Management, LLC | $1,199,250 | 307,500 | 0.48% | Shares |
| Polymer Capital Management (HK) LTD | $1,195,666 | 306,581 | 0.48% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,141,639 | 292,728 | 0.46% | Shares |
| JANE STREET GROUP, LLC | $883,350 | 226,500 | 0.35% | Put option |
| TWO SIGMA INVESTMENTS, LP | $837,065 | 214,632 | 0.33% | Shares |
| GOLDMAN SACHS GROUP INC | $543,578 | 139,379 | 0.22% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $412,160 | 105,682 | 0.16% | Shares |
| Simplify Asset Management Inc. | $408,911 | 104,849 | 0.16% | Shares |
| AMERICAN CENTURY COMPANIES INC | $330,271 | 84,685 | 0.13% | Shares |
| CITADEL ADVISORS LLC | $315,900 | 81,000 | 0.13% | Call option |
| ALPS ADVISORS INC | $302,640 | 77,600 | 0.12% | Shares |
| Stonepine Capital Management, LLC | $285,757 | 73,271 | 0.11% | Shares |
| VANGUARD GROUP INC | $279,602 | 74,760 | 0.11% | Shares |
| CITADEL ADVISORS LLC | $244,908 | 62,797 | 0.10% | Shares |
| Nuveen, LLC | $227,752 | 58,398 | 0.09% | Shares |
| JANE STREET GROUP, LLC | $209,040 | 53,600 | 0.08% | Call option |
| Pathstone Holdings, LLC | $197,537 | 50,650 | 0.08% | Shares |
| Kestra Advisory Services, LLC | $194,263 | 49,811 | 0.08% | Shares |
| RHUMBLINE ADVISERS | $176,133 | 45,164 | 0.07% | Shares |
| DEUTSCHE BANK AG\ | $165,247 | 42,371 | 0.07% | Shares |
| IFP Advisors, Inc | $150,926 | 38,699 | 0.06% | Shares |
| Bank of New York Mellon Corp | $146,500 | 37,564 | 0.06% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $110,760 | 28,400 | 0.04% | Call option |
| MetLife Investment Management, LLC | $109,259 | 28,015 | 0.04% | Shares |
| ALLIANCEBERNSTEIN L.P. | $105,183 | 26,970 | 0.04% | Shares |
| Persistent Asset Partners Ltd | $99,060 | 25,400 | 0.04% | Shares |
| BANK OF AMERICA CORP /DE/ | $97,991 | 25,126 | 0.04% | Shares |
| CITIGROUP INC | $93,904 | 24,078 | 0.04% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $77,984 | 19,996 | 0.03% | Shares |
| Scientech Research LLC | $68,039 | 17,446 | 0.03% | Shares |
| Invesco Ltd. | $67,532 | 17,316 | 0.03% | Shares |
| Quadrature Capital Ltd | $59,261 | 15,195 | 0.02% | Shares |
| JANE STREET GROUP, LLC | $57,073 | 14,634 | 0.02% | Shares |
| BARCLAYS PLC | $54,207 | 13,899 | 0.02% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $50,493 | 12,947 | 0.02% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $50,310 | 12,900 | 0.02% | Shares |
| Miller Capital Partners, Inc. | $50,193 | 12,870 | 0.02% | Shares |
| Police & Firemen's Retirement System of New Jersey | $49,947 | 12,807 | 0.02% | Shares |
| Vanguard Global Advisers, LLC | $46,223 | 11,852 | 0.02% | Shares |
| PNC Financial Services Group, Inc. | $40,053 | 10,270 | 0.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $33,669 | 8,633 | 0.01% | Shares |
| STRS OHIO | $33,150 | 8,500 | 0.01% | Shares |
| WELLS FARGO & COMPANY/MN | $30,081 | 7,713 | 0.01% | Shares |
| NORTHERN TRUST CORP | $26,571 | 6,813 | 0.01% | Shares |
| Plante Moran Financial Advisors, LLC | $23,108 | 5,925 | 0.01% | Shares |
| OSAIC HOLDINGS, INC. | $21,585 | 5,535 | 0.01% | Shares |
| BlackRock, Inc. | $16,875 | 4,327 | 0.01% | Shares |
| Legal & General Group Plc | $16,470 | 4,223 | 0.01% | Shares |
| Ameritas Investment Partners, Inc. | $15,370 | 3,941 | 0.01% | Shares |
| Russell Investments Group, Ltd. | $13,540 | 3,472 | 0.01% | Shares |
| Tower Research Capital LLC (TRC) | $9,828 | 2,520 | 0.00% | Shares |
| UBS Group AG | $8,385 | 2,150 | 0.00% | Shares |
| Federation des caisses Desjardins du Quebec | $7,800 | 2,000 | 0.00% | Shares |
| GROUP ONE TRADING LLC | $7,223 | 1,852 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $6,000 | 1,533 | 0.00% | Shares |
| Truvestments Capital LLC | $4,290 | 1,100 | 0.00% | Shares |
| Sterling Capital Management LLC | $3,413 | 875 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $2,894 | 742 | 0.00% | Shares |
| MORGAN STANLEY | $850 | 218 | 0.00% | Shares |
| GS Investments, Inc. | $780 | 200 | 0.00% | Shares |
| FMR LLC | $452 | 116 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $339 | 87 | 0.00% | Shares |
| HARBOUR INVESTMENTS, INC. | $195 | 50 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $139 | 35,620 | 0.00% | Shares |
| First PREMIER Bank | $74 | 18,986 | 0.00% | Shares |
Company insiders 24 insiders · 12 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Samuel J Reich | CEO | Feb. 3, 2026 A | 219,001 | 0 | 0 | $0 |
| Lucy To | Chief Financial Officer | Feb. 3, 2026 A | — | 0 | 0 | $0 |
| Michael King | CHIEF FINANCIAL OFFICER | Feb. 21, 2024 A | 5,000 | 0 | 0 | $0 |
| Beyer Russell P | CHIEF FINANCIAL OFFICER | Sept. 13, 2022 A | — | 0 | 0 | $0 |
| Eddie Joe Sullivan | PRESIDENT | Feb. 3, 2026 A | 5,232,304 | 0 | 0 | $0 |
| Christoph Lawrence Bausch | CHIEF OPERATING OFFICER | Feb. 3, 2026 A | — | 0 | 0 | $0 |
| Bruce Kipp Erickson | Chief Operating Officer | March 16, 2022 A | — | 0 | 0 | $0 |
| Alexandra Kropotova | CHIEF MEDICAL OFFICER | March 24, 2026 F | 43,296 | 0 | 0 | $0 |
| Melissa Vera Ullerich | Chief Communications Officer | March 16, 2022 A | — | 0 | 0 | $0 |
| Thomas Charles Luke | Chief Medical Officer | March 16, 2022 A | — | 0 | 0 | $0 |
| Jerry Lynn Pommer | Chief Compliance Officer | March 16, 2022 A | — | 0 | 0 | $0 |
| Frederick Finnegan | Chief Business Officer | March 16, 2022 A | — | 0 | 0 | $0 |
| Rita Jain | Director | Jan. 5, 2026 A | — | 0 | 0 | $0 |
| David Zaccardelli | Director | Jan. 5, 2026 A | — | 0 | 0 | $0 |
| David Link | Director | Dec. 16, 2025 A | — | 0 | 0 | $0 |
| Helen K. Ellias | Director | Dec. 16, 2025 A | 2,857,142 | 0 | 0 | $0 |
| Scott Giberson | Director | Dec. 16, 2025 A | — | 0 | 0 | $0 |
| William James Polvino | Director | Dec. 16, 2025 A | — | 0 | 0 | $0 |
| Jay S Skyler | Director | Dec. 16, 2025 A | — | 0 | 0 | $0 |
| Andrew Moin | Director | Sept. 29, 2025 M | 2,198,457 | 0 | 0 | $0 |
| David Charles Link | Director | July 15, 2024 A | 57,313 | 0 | 0 | $0 |
| Jeffrey G Spragens | Director | July 15, 2024 A | 394,989 | 0 | 0 | $0 |
| Christine E Hamilton | Director | July 15, 2024 A | 3,111,334 | 0 | 0 | $0 |
| Erick Lucera | — | Dec. 16, 2025 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×2 filings | March 11, 2026 | 9.90% | Amendment | — | SEC |
| Christine Hamilton, Edward Hamilton ×2 filings | Dec. 16, 2022 | — | Initial filing | — | SEC |
| Eddie Joe Sullivan | Sept. 8, 2022 | — | Initial filing | Passive investment | SEC |
| Big Cypress Holdings LLC, Samuel J. Reich ×2 filings | May 27, 2022 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 9 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 67,679 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | July 15, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | — | — | July 15, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| IWN · iShares Trust | — | — | Aug. 17, 2026 | Daily |
| IWM · iShares Trust | — | — | Aug. 18, 2026 | Daily |
| IWC · iShares Trust | — | — | Aug. 18, 2026 | Daily |